By Yafo Life Sciences
December 26th, 2021 (Shanghai) — We are glad to announce that Hanwei Yin, the Director of R&D of Yuanxi Medicine Corp., has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan13th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.
If you are interested in listening to the live event, please register at https://biotochina.org/register/
About Yuanxi Medicine Corp.
- A biotech company dedicated to the R&D of chemical drugs for the treatment of diseases such as fibrosis and tumors.
- R&D pipelines are mainly focused on the first-in-class drugs with globally novel targets, all of which have independent intellectual property rights globally. The indications are aiming to meet the major unmet clinical needs.
About the speaker
Dr.Hanwei Yin has received his Ph.D.degree in Feinberg School of Medicine, Northwestern University. He serves as the director of R&D department in Yuanxi Medicine Corp. since 2019, and he is in charge of the clinical operation of BS1801.
About ACCESS CHINA
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/
Contact US
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 